Clinical Trials Logo

Clinical Trial Summary

SMOF is a large double blind placebo-controlled randomized clinical trial aiming to compare the rate of bronchopulmonary dysplasia (BPD) at 36 weeks corrected age in premature infants < 29 weeks and / or with birth weight < 1000 g receiving either SMOFlipid® or Medialipide® 20%. This study will offer new information for optimizing the management of preterms requiring parenteral nutrition. The investigators hypothesis is that the composition of SMOFlipid may decrease lipid peroxidation and oxidative stress in preterms, resulting in a lower incidence of BPD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02853253
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Withdrawn
Phase Phase 4
Start date January 2017
Completion date May 2019

See also
  Status Clinical Trial Phase
Completed NCT05957900 - Neurobehavioral Responses to Multisensory Stimulation Module in Preterm Neonates N/A
Completed NCT06173622 - Effects of Fetal Positioning During Venipuncture N/A
Completed NCT04122300 - Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct Phase 3
Completed NCT03147846 - The Hematologic Impact of Umbilical Cord Milking Versus Deferred Cord Clamping in Premature Neonates. N/A
Recruiting NCT02798926 - Polyethylene Bag: a Way of Preventing Hypothermia During Central Venous Catheter Placement in Preterm Neonates? N/A
Completed NCT01215591 - Trial of Weaning of Nasal Continuous Positive Airway Pressure (CPAP) N/A
Completed NCT05892081 - Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit Phase 4